156 related articles for article (PubMed ID: 26555233)
1. The highly alloreactive nature of dual TCR T cells.
Balakrishnan A; Morris GP
Curr Opin Organ Transplant; 2016 Feb; 21(1):22-8. PubMed ID: 26555233
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease.
Morris GP; Allen PM
J Immunol; 2009 Jun; 182(11):6639-43. PubMed ID: 19454656
[TBL] [Abstract][Full Text] [Related]
3. Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.
Morris GP; Uy GL; Donermeyer D; Dipersio JF; Allen PM
Sci Transl Med; 2013 Jun; 5(188):188ra74. PubMed ID: 23740900
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Generation of human alloantigen-specific T cells from peripheral blood.
Jama BP; Morris GP
J Vis Exp; 2014 Nov; (93):e52257. PubMed ID: 25490283
[TBL] [Abstract][Full Text] [Related]
6. Analysis of T-Cell Receptor Repertoire in Transplantation: Fingerprint of T Cell-mediated Alloresponse.
Tian G; Li M; Lv G
Front Immunol; 2021; 12():778559. PubMed ID: 35095851
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.
Balakrishnan A; Gloude N; Sasik R; Ball ED; Morris GP
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1852-1860. PubMed ID: 28750779
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.
Imamura M; Tsutsumi Y; Miura Y; Toubai T; Tanaka J
Hematology; 2003 Feb; 8(1):19-26. PubMed ID: 12623423
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
11. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
[TBL] [Abstract][Full Text] [Related]
12. High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity.
Fu J; Khosravi-Maharlooei M; Sykes M
Front Immunol; 2021; 12():777756. PubMed ID: 34804070
[TBL] [Abstract][Full Text] [Related]
13. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
14. Potential of TCR sequencing in graft-versus-host disease.
Goel M; Eugster A; Schetelig J; Bonifacio E; Bornhäuser M; Link-Rachner CS
Bone Marrow Transplant; 2023 Mar; 58(3):239-246. PubMed ID: 36477111
[TBL] [Abstract][Full Text] [Related]
15. Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells.
Daniele N; Scerpa MC; Caniglia M; Bernardo ME; Rossi C; Ciammetti C; Palumbo G; Locatelli F; Isacchi G; Zinno F
Pathol Res Pract; 2012 Feb; 208(2):67-73. PubMed ID: 22115749
[TBL] [Abstract][Full Text] [Related]
16. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
[TBL] [Abstract][Full Text] [Related]
17. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Hess AD
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
[TBL] [Abstract][Full Text] [Related]
18. Allorecognition and graft-versus-host disease.
Theobald M
Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
[TBL] [Abstract][Full Text] [Related]
19. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
20. One is better than two: TCR pairing and GVHD.
Vincent BG; Serody JS
Sci Transl Med; 2013 Jun; 5(188):188fs21. PubMed ID: 23740895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
